Relapsed Refractory B Cell Acute Lymphoblastic Leukemia clinical trials

Explore recruiting relapsed refractory b cell acute lymphoblastic leukemia clinical trials.

Recruiting relapsed refractory b cell acute lymphoblastic leukemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Relapsed Refractory B Cell Acute Lymphoblastic Leukemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase I clinical trial on the use of fresh, allogeneic, second-generation CD19-CAR T cells for treatment of children and young adult with relapsed/refractory B-cell Acute Lymphoblastic Leukemia

Italy

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 2/3, Randomized, Open-Label, Comparison Study of MK-1045 Versus Blinatumomab in Participants With Relapsed or Refractory CD19+ B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Greece, Netherlands, Sweden, France, Italy, Spain +1 more

Phase II and Phase III (Integrated) EU CTIS Study details

Relapsed Refractory B Cell Acute Lymphoblastic Leukemia trials by city

Relapsed Refractory B Cell Acute Lymphoblastic Leukemia in Toronto Relapsed Refractory B Cell Acute Lymphoblastic Leukemia in Vancouver Relapsed Refractory B Cell Acute Lymphoblastic Leukemia in Montreal Relapsed Refractory B Cell Acute Lymphoblastic Leukemia in Calgary Relapsed Refractory B Cell Acute Lymphoblastic Leukemia in Edmonton Relapsed Refractory B Cell Acute Lymphoblastic Leukemia in Ottawa Relapsed Refractory B Cell Acute Lymphoblastic Leukemia in Winnipeg Relapsed Refractory B Cell Acute Lymphoblastic Leukemia in Quebec City Relapsed Refractory B Cell Acute Lymphoblastic Leukemia in Hamilton Relapsed Refractory B Cell Acute Lymphoblastic Leukemia in Kitchener Relapsed Refractory B Cell Acute Lymphoblastic Leukemia in London Relapsed Refractory B Cell Acute Lymphoblastic Leukemia in Halifax Relapsed Refractory B Cell Acute Lymphoblastic Leukemia in New York Relapsed Refractory B Cell Acute Lymphoblastic Leukemia in Los Angeles Relapsed Refractory B Cell Acute Lymphoblastic Leukemia in Chicago Relapsed Refractory B Cell Acute Lymphoblastic Leukemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease